Normalizing the results to the WT control group further demonstrated the remarkable tumor suppression effect of HO-1 KO on tumor growth in the control group implanted with HO-1 KO RM-1 and in the group treated with Doc compared to the WT groups (P < 0.05) (Fig. 2E and F). The gene discussed is TIPARP; the disease is neoplasm.